PRINS RICHARD K 4
4 · IGC Pharma, Inc. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
PRINS RICHARD K
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-19+100,000→ 1,371,251 total - Exercise/Conversion
Restricted Stock Units
[F2][F1]2026-01-19−100,000→ 50,000 total→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
- [F2]Each restricted stock unit represents a right to receive one share of IGC common stock.
Signature
/s/ Richard Prins|2026-01-20